Shujun Xie

机构：Westlake University, Hangzhou First People's Hospital · ORCID：0000-0002-1582-9175

发表论文 32 篇 · 总被引 1748 次 · h-index 15

代表论文

• SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer (2021 · Cancer Letters · 被引 95)
• Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination (2018 · Toxicology and Applied Pharmacology · 被引 77)
• Ticagrelor inhibits the NLRP3 inflammasome to protect against inflammatory disease independent of the P2Y12 signaling pathway (2020 · Cellular and Molecular Immunology · 被引 71)
• Targeting macrophagic PIM-1 alleviates osteoarthritis by inhibiting NLRP3 inflammasome activation via suppressing mitochondrial ROS/Cl− efflux signaling pathway (2023 · Journal of Translational Medicine · 被引 47)
• Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMT (2020 · Acta Pharmacologica Sinica · 被引 47)
• Cypermethrin Promotes Lung Cancer Metastasis via Modulation of Macrophage Polarization by Targeting MicroRNA-155/Bcl6 (2018 · Toxicological Sciences · 被引 41)